~~<i id='9243002AFB'><strike id='9243002AFB'><tt id='9243002AFB'><pre id='9243002AFB'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

author：explore 2025-10-01 15:33:01 Page View：42

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： South Korea throws huge K
Next article： Apple is now the first public company to be valued at $3 trillion

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

2:51AnaerialviewshowsawildfireinMauiCounty,Hawaii,August8,2023inthisscreengrabobtainedfromasocialmed

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Asbestos ban is immediate, but health effects will linger for decades

BrookMitchell/GettyImagesAnewruleannouncedbytheEnvironmentalProtectionAgencythisweekputsanendtotheus